The purpose of this investigation is to evaluate the safety and superior effectiveness in
functional improvement in patients with partial-thickness rotator cuff tears (PTRCTs) after
the administration of a single injection of adipose-derived regenerative cells (ADRCs) into
the partial-thickness rotator cuff tear compared to the administration of a single
corticosteroid injection into the associated subacromial space.